SAMMARTANO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 2.054
NA - Nord America 1.864
AS - Asia 1.105
SA - Sud America 201
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 62
OC - Oceania 3
Totale 5.398
Nazione #
US - Stati Uniti d'America 1.781
RU - Federazione Russa 587
IT - Italia 534
SG - Singapore 379
CN - Cina 278
IE - Irlanda 217
DE - Germania 184
BR - Brasile 161
GB - Regno Unito 140
FI - Finlandia 123
VN - Vietnam 104
HK - Hong Kong 86
FR - Francia 79
SE - Svezia 66
KR - Corea 56
IN - India 55
BD - Bangladesh 48
CA - Canada 42
ZA - Sudafrica 36
NL - Olanda 29
LT - Lituania 17
AR - Argentina 16
MX - Messico 15
JP - Giappone 14
PL - Polonia 14
ES - Italia 13
IQ - Iraq 11
AT - Austria 10
CZ - Repubblica Ceca 10
TR - Turchia 9
PK - Pakistan 8
UA - Ucraina 8
CO - Colombia 6
CR - Costa Rica 6
EC - Ecuador 6
IR - Iran 6
EG - Egitto 5
GP - Guadalupe 5
ID - Indonesia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
MY - Malesia 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
ET - Etiopia 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
SC - Seychelles 3
CI - Costa d'Avorio 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
PR - Porto Rico 2
TN - Tunisia 2
VE - Venezuela 2
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GR - Grecia 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 5.289
Città #
Dallas 287
Singapore 270
Dublin 216
Ashburn 173
San Jose 170
Moscow 151
Munich 135
Santa Clara 119
Milan 105
Hefei 91
Helsinki 85
Council Bluffs 83
Hong Kong 81
Southend 76
Siena 73
Beijing 66
New York 61
Chandler 58
Seoul 54
Los Angeles 53
Rome 46
Fairfield 45
Florence 39
Ho Chi Minh City 37
The Dalles 35
Johannesburg 32
Lauterbourg 31
Woodbridge 24
Seattle 23
São Paulo 23
Turin 23
Turku 23
Hanoi 21
Cambridge 20
Buffalo 18
Houston 18
Shanghai 18
Princeton 17
Columbus 15
Figino 15
Nuremberg 15
Bengaluru 14
Wilmington 14
Chicago 13
Lappeenranta 13
Toronto 13
Washington 13
Chennai 12
Montreal 12
Vilnius 12
Warsaw 12
Frankfurt am Main 11
London 11
Orem 11
Portsmouth 11
Redondo Beach 11
Boston 10
Denver 10
San Francisco 10
Tokyo 10
Atlanta 9
Messina 9
Mumbai 9
Rio de Janeiro 9
Brooklyn 8
Naples 8
Boardman 7
Da Nang 7
Vienna 7
Brno 6
Phoenix 6
Dearborn 5
Fremont 5
Haiphong 5
Mexico City 5
Miami 5
Modena 5
Querétaro 5
San Diego 5
San José 5
Stockholm 5
Vancouver 5
Amsterdam 4
Bergamo 4
Dong Ket 4
Florissant 4
Las Vegas 4
Manchester 4
Parma 4
Perugia 4
Poplar 4
Porto Alegre 4
San Mateo 4
Secaucus 4
Tashkent 4
Verona 4
Baghdad 3
Biên Hòa 3
Brasília 3
Buscate 3
Totale 3.376
Nome #
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 303
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 262
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy 254
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 250
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin 243
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 233
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 229
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 216
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 216
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency 208
Prognostic value of CD47 overexpression measured by flow cytometry in patients with acute myeloid leukemia 208
Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells 207
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 207
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 200
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 198
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network) 194
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 177
Functional imaging in the evaluation of treatment response in multiple myeloma: the role of PET-CT and MRI 175
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 174
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) 171
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 169
Anti-BCMA novel therapies for multiple myeloma 156
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 154
Central nervous system myeloma and unusual extramedullary localizations: real life practical guidance 149
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 142
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy 133
Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs 115
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 55
Totale 5.398
Categoria #
all - tutte 17.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 0 1 5 2 3 5 13 33 36
2022/2023330 13 32 35 33 23 37 24 32 23 6 66 6
2023/2024491 9 14 48 32 30 114 157 16 13 27 4 27
2024/20251.118 34 31 99 54 86 106 96 87 119 50 134 222
2025/20262.627 170 301 265 392 595 102 230 52 65 153 71 231
2026/2027452 109 86 95 128 34 0 0 0 0 0 0 0
Totale 5.398